These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36527724)

  • 1. Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data.
    Yang J; Vaghela S; Yarnoff B; De Boisvilliers S; Di Fusco M; Wiemken TL; Kyaw MH; McLaughlin JM; Nguyen JL
    Expert Rev Vaccines; 2023; 22(1):54-65. PubMed ID: 36527724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study.
    Savinkina A; Bilinski A; Fitzpatrick M; Paltiel AD; Rizvi Z; Salomon J; Thornhill T; Gonsalves G
    BMJ Open; 2022 Sep; 12(9):e061752. PubMed ID: 36100306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States.
    Di Fusco M; Marczell K; Deger KA; Moran MM; Wiemken TL; Cane A; de Boisvilliers S; Yang J; Vaghela S; Roiz J
    J Med Econ; 2022; 25(1):605-617. PubMed ID: 35574613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19.
    Patenaude B; Ballreich J
    BMC Public Health; 2022 Sep; 22(1):1792. PubMed ID: 36131266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States.
    Di Fusco M; Marczell K; Thoburn E; Wiemken TL; Yang J; Yarnoff B
    J Med Econ; 2023; 26(1):509-524. PubMed ID: 36942976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021.
    Mendes D; Chapman R; Gal P; Atwell J; Nguyen JL; Hamson L; Di Fusco M; Czudek C; Yang J
    J Med Econ; 2022; 25(1):1039-1050. PubMed ID: 36097853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore.
    Thakkar K; Spinardi J; Kyaw MH; Yang J; Mendoza CF; Ozbilgili E; Taysi B; Dodd J; Yarnoff B; Oh HM
    Expert Rev Vaccines; 2024; 23(1):16-26. PubMed ID: 38047434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccination and Estimated Public Health Impact in California.
    Tan ST; Park HJ; Rodríguez-Barraquer I; Rutherford GW; Bibbins-Domingo K; Schechter R; Lo NC
    JAMA Netw Open; 2022 Apr; 5(4):e228526. PubMed ID: 35452106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit-Cost Analysis of the HHS COVID-19 Campaign: April 2021-March 2022.
    Turner S; Kranzler EC; Trigger S; Kearsley A; Luchman JN; Williams CJ; Denison B; Dahlen H; Kim JC; Bennett M; Nighbor T; Beleche T; Hoffman L; Peck J
    Am J Prev Med; 2024 Aug; 67(2):258-264. PubMed ID: 38713123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
    Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC
    Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia.
    Thakkar K; Spinardi J; Kyaw MH; Yang J; Mendoza CF; Dass M; Law W; Ozbilgili E; Yarnoff B
    Expert Rev Vaccines; 2023; 22(1):714-725. PubMed ID: 37548520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.
    Paltiel AD; Zheng A; Sax PE
    Ann Intern Med; 2021 Jun; 174(6):803-810. PubMed ID: 33683930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand.
    Thakkar K; Spinardi J; Kyaw MH; Yang J; Mendoza CF; Ozbilgili E; Dodd J; Yarnoff B; Punrin S
    Expert Rev Vaccines; 2023; 22(1):860-870. PubMed ID: 37779484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Return on Investment of the COVID-19 Vaccination Campaign in New York City.
    Sah P; Vilches TN; Moghadas SM; Pandey A; Gondi S; Schneider EC; Singer J; Chokshi DA; Galvani AP
    JAMA Netw Open; 2022 Nov; 5(11):e2243127. PubMed ID: 36409495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.
    Yamana TK; Galanti M; Pei S; Di Fusco M; Angulo FJ; Moran MM; Khan F; Swerdlow DL; Shaman J
    PLoS One; 2023; 18(4):e0275699. PubMed ID: 37098043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Constenla D; Liu T
    Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021.
    Meslé MM; Brown J; Mook P; Hagan J; Pastore R; Bundle N; Spiteri G; Ravasi G; Nicolay N; Andrews N; Dykhanovska T; Mossong J; Sadkowska-Todys M; Nikiforova R; Riccardo F; Meijerink H; Mazagatos C; Kyncl J; McMenamin J; Melillo T; Kaoustou S; Lévy-Bruhl D; Haarhuis F; Rich R; Kall M; Nitzan D; Smallwood C; Pebody RG
    Euro Surveill; 2021 Nov; 26(47):. PubMed ID: 34823641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.
    He D; Ali ST; Fan G; Gao D; Song H; Lou Y; Zhao S; Cowling BJ; Stone L
    Emerg Infect Dis; 2022 Sep; 28(9):1873-1876. PubMed ID: 35914516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.
    Frost JJ; Sonfield A; Zolna MR; Finer LB
    Milbank Q; 2014 Dec; 92(4):696-749. PubMed ID: 25314928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.